News

FDA appears to be slow-walking vaccine approvals
Former government health officials fear the Trump administration is moving to slow-walk vaccine approvals, including by ...
FDA scrutiny of Novavax COVID-19 vaccine sparks uncertainty about other shots
There’s new uncertainty about updated COVID-19 shots this fall after the Trump administration’s handling of a shot from ...
BioPharma Dive5h
Novavax says vaccine application still ‘approvable,’ despite FDA delay
Comments over the weekend by FDA chief Martin Makary suggest the agency views Novavax’s updated COVID shot as a “new product” ...
Infectious Disease Advisor8h
Novavax COVID-19 Vaccine Moves Closer to Full FDA Approval
Novavax’s COVID-19 vaccine could soon receive full approval from the United States Food and Drug Administration.
STAT9h
U.S. health officials inject new uncertainty into approval process for Covid boosters
Confusion over the FDA delay in granting full approval to Novavax’s Covid-19 vaccine deepened over the weekend, with possible ...
FDA may ask Novavax to conduct additional trials of its Covid-19 vaccine to receive full approval
The US Food and Drug Administration has discussed with vaccine-maker Novavax the need for an additional trial of its Covid-19 ...
Novavax told by FDA to conduct additional study for COVID vaccine - report
Novavax faces a setback as the FDA requests an additional trial for COVID-19 vaccine approval. Read more here.